Testing Monotonicity of Mean Potential Outcomes in a Continuous Treatment with High-Dimensional Data
Yu-Chin Hsu, Martin Huber, Ying-Ying Lee, Chu-An Liu

TL;DR
This paper introduces a novel statistical test for assessing the monotonic relationship between a continuous treatment and mean potential outcomes, using high-dimensional covariates and machine learning techniques, with theoretical guarantees and empirical validation.
Contribution
It develops a Cramér-von Mises-type test combined with a double debiased machine learning estimator to handle high-dimensional covariates in continuous treatment settings.
Findings
Test controls asymptotic size effectively.
Test is consistent against fixed alternatives.
Empirical application rejects weak negative relationship.
Abstract
While most treatment evaluations focus on binary interventions, a growing literature also considers continuously distributed treatments. We propose a Cram\'{e}r-von Mises-type test for testing whether the mean potential outcome given a specific treatment has a weakly monotonic relationship with the treatment dose under a weak unconfoundedness assumption. In a nonseparable structural model, applying our method amounts to testing monotonicity of the average structural function in the continuous treatment of interest. To flexibly control for a possibly high-dimensional set of covariates in our testing approach, we propose a double debiased machine learning estimator that accounts for covariates in a data-driven way. We show that the proposed test controls asymptotic size and is consistent against any fixed alternative. These theoretical findings are supported by the Monte-Carlo…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAdvanced Causal Inference Techniques · Statistical Methods and Inference · Health Systems, Economic Evaluations, Quality of Life
